The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, double-blind phase II study of pembrolizumab versus placebo in patients with head and neck cancers at high risk for recurrence or low-volume residual disease: The PATHWay Study.
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech; Guardant Health; Merck
Research Funding - Bayer (Inst); Carevive Systems (Inst); Incyte; Merck (Inst); Novartis (Inst)
 
Theodore Karrison
No Relationships to Disclose
 
Everett E. Vokes
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Leidos Biomedical Research; Lilly; Merck; Merck Serono; Regeneron; Takeda; VentiRx
 
Roger B. Cohen
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Cerulean Pharma; GlaxoSmithKline; Heat Biologics; Kolltan Pharmaceuticals; Takeda
Research Funding - Cleave Biosciences (Inst); Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Takeda
 
Jonas A. De Souza
No Relationships to Disclose
 
Charu Aggarwal
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Genentech (I); Novartis (I); Pfizer (I)
Research Funding - Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Millennium (Inst); Nektar (Inst)
 
Vassiliki Saloura
No Relationships to Disclose
 
Nishant Agrawal
No Relationships to Disclose
 
Nabil F. Saba
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer
 
Corey J. Langer
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Lilly/ImClone; Merck
Research Funding - Advantagene (Inst); Ariad (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Stem CentRx (Inst)
 
Tanguy Y. Seiwert
Honoraria - Merck